|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/506 | (2006.01) |
| A61K 45/00 | (2013.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61K 31/506 | (2013.01) |
| (11) | Number of the document | 3920970 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20702304.5 |
| Date of filing the European patent application | 2020-02-03 | |
| (97) | Date of publication of the European application | 2021-12-15 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2020/052554 |
| Date | 2020-02-03 |
| (87) | Number | WO 2020/161045 |
| Date | 2020-08-13 |
| (30) | Number | Date | Country code |
| 19305128 | 2019-02-04 | EP |
| (72) |
SALEM, Joe-Elie , FR
ALLENBACH, Yves , FR
KERNEIS, Mathieu , FR
MOSLEHI, Javid , US
JOHNSON, Douglas , US
|
| (73) |
Assistance Publique Hôpitaux de Paris ,
55 boulevard Diderot, 75012 Paris,
FR
Sorbonne Université , 21 Rue de l'Ecole de Médecine, 75006 Paris, FR Institut National de la Santé et de la Recherche Médicale (INSERM) , 101 rue de Tolbiac, 75013 Paris, FR Vanderbilt University , 305 Kirkland Hall 2201 West End Avenue, Nashville, TN 37240, US |
| (54) | METHOD FOR TREATING CHECKPOINT INHIBITORS INDUCED ADVERSE EVENTS |
| METHOD FOR TREATING CHECKPOINT INHIBITORS INDUCED ADVERSE EVENTS |